<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0120-5633</journal-id>
<journal-title><![CDATA[Revista Colombiana de Cardiología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. Colomb. Cardiol.]]></abbrev-journal-title>
<issn>0120-5633</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Colombiana de Cardiologia. Oficina de Publicaciones]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0120-56332017000400334</article-id>
<article-id pub-id-type="doi">10.1016/j.rccar.2016.08.002</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Determinación del riesgo cardiovascular en una población]]></article-title>
<article-title xml:lang="en"><![CDATA[Determining cardiovascular risk in a population group]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Álvarez-Ceballos]]></surname>
<given-names><![CDATA[Juan Camilo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Álvarez-Múñoz]]></surname>
<given-names><![CDATA[Andrés M.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Carvajal-Gutiérrez]]></surname>
<given-names><![CDATA[Wilder]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[María Mercedes]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Duque]]></surname>
<given-names><![CDATA[Jorge Luis]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Nieto-Cárdenas]]></surname>
<given-names><![CDATA[Olga Alicia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad del Quindío Grupo de Salud Pública ]]></institution>
<addr-line><![CDATA[Quindío ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad del Quindío Facultad de Ciencias de la Salud ]]></institution>
<addr-line><![CDATA[Quindío ]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>08</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>08</month>
<year>2017</year>
</pub-date>
<volume>24</volume>
<numero>4</numero>
<fpage>334</fpage>
<lpage>341</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0120-56332017000400334&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0120-56332017000400334&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0120-56332017000400334&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Objetivo:  Determinar el riesgo cardiovascular con las escalas Framingham, Framingham Colombia, Procam y Procam Colombia en la población del programa de riesgo cardiovascular de una institución de salud de primer nivel en la ciudad de Armenia, Quindío.  Métodos:  Se realizó un estudio descriptivo de corte transversal, que tomó como población las personas del programa de riesgo cardiovascular de una institución de salud de primer nivel en la ciudad de Armenia, Quindío, entre el 1 de enero y 31 de diciembre de 2015. Se describieron las variables en promedio, desviación estándar e intervalos de confianza, con un análisis comparativo por sexo para los factores de riesgo en cada escala.  Resultados:  En la población del programa de riesgo cardiovascular se encontró, un promedio de edad de 64,54 años e índice de masa corporal de 27,71 m2/kg. El 76,48% presenta hipertensión arterial, el 20,86% presenta diabetes mellitus y el 9,36% fuma. El riesgo cardiovascular calculado con la escala de Framingham es el 11,36% y con Framingham Colombia es el 8,52%. Con la escala Procam es el 9,44% y con Procam Colombia es el 8,81%. El índice de masa corporal, la edad y el colesterol LDL, no son estadísticamente significativos para la valoración del riesgo con las escalas Framingham y Framingham Colombia.  Conclusiones:  Se propone que la escala adecuada para la medición del riesgo cardiovascular en esta población es la escala de Procam o Procam Colombia, porque identifica casi todas las variables de manera significativa. Las escalas de Framingham y Framingham Colombia deben ser utilizadas con precaución en esta población.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Motivation:  To determine cardiovascular risk with Framingham, Framingham Colombia, Procam, and Procam Colombia in the population of the cardiovascular risk program of a first level institution in the city of Armenia, Quindío.  Methods:  A cross-sectional, descriptive study was conducted that selected as population the participants of the cardiovascular risk program of a first level health institution in the city of Armenia, Quindío, between 1st of January and 31st of December 2015. Average variables, standard deviation and confidence intervals were described with a comparative gender-sensitive analysis of risk factors for each scale.  Results:  The average age in the cardiovascular risk program was 64.54 years, and a body mass index of 27.71 m2/kg. 76.48% presents arterial hypertension, 20.86% diabetes mellitus and 9.36% smoke. Cardiovascular risk according to the Framingham scale is 11.36%, and with Framingham Colombia it is 8.52%. According to Procam scale it is 9.44%, and with Procam Colombia it is 8.81%. Body mass index, age and LDL cholesterol are not statistically significant for risk assessment with Framingham and Framingham Colombia scales.  Conclusion:  The proposed appropriate scale for measuring cardiovascular risk in this population group is the Procam or Procam Colombia scale, because it identifies almost all variables in a significant way. Framingham and Framingham Colombia scales must be used with caution for this population group]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Enfermedad cardiovascular]]></kwd>
<kwd lng="es"><![CDATA[Factores de riesgo cardiovascular]]></kwd>
<kwd lng="es"><![CDATA[Estudios de validación]]></kwd>
<kwd lng="en"><![CDATA[Cardiovascular disease]]></kwd>
<kwd lng="en"><![CDATA[Cardiovascular risk factors]]></kwd>
<kwd lng="en"><![CDATA[Validation studies]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<collab>Organización Panamericana de la Salud</collab>
<source><![CDATA[prevención de las enfermedades cardiovasculares, directrices para la evaluación y el manejo del riesgo cardiovascular]]></source>
<year>2010</year>
<publisher-name><![CDATA[OPS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Factores de riesgo cardiovascular]]></article-title>
<source><![CDATA[Instituto del Corazón de Texas (Texas Heart Institute)]]></source>
<year>2016</year>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<collab>Instituto Nacional de Salud</collab>
<article-title xml:lang=""><![CDATA[Enfermedad cardiovascular: principal causa de muerte en Colombia]]></article-title>
<source><![CDATA[Observatorio Nacional de Salud]]></source>
<year>2013</year>
<volume>1</volume>
<page-range>1-6</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<collab>Organización Mundial de la Salud</collab>
<source><![CDATA[Las 10 causas principales de defunción en el mundo]]></source>
<year>2014</year>
<publisher-loc><![CDATA[Ginebra ]]></publisher-loc>
<publisher-name><![CDATA[centro de prensa OMS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gómez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cardiovascular morbidity and mortality in the world Rev. Colomb]]></article-title>
<source><![CDATA[Cardiol]]></source>
<year>2012</year>
<volume>9</volume>
<page-range>298-9</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="">
<collab>Ministerio Nacional de Salud de Colombia</collab>
<source><![CDATA[Plan Decenal de Salud Pública, PDSP. 2012: La salud en Colombia la construyes tú]]></source>
<year>2013</year>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="book">
<source><![CDATA[Principales causas de mortalidad en Colombia]]></source>
<year>2010</year>
<publisher-loc><![CDATA[Bogotá, Colombia ]]></publisher-loc>
<publisher-name><![CDATA[Ministerio de Salud y Protección Social]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="">
<collab>Gobernación del Quindío, Secretaria de Salud Departamental</collab>
<source><![CDATA[Análisis de la situación de salud en el departamento.]]></source>
<year>2012</year>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Álvarez Cosmea]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Las tablas de riesgo cardiovascular Una revisión crítica]]></article-title>
<source><![CDATA[Medifam]]></source>
<year>2001</year>
<volume>11</volume>
<page-range>20-51</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Múñoz]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz]]></surname>
<given-names><![CDATA[Á]]></given-names>
</name>
<name>
<surname><![CDATA[Rondón]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Validación de los modelos de predicción de Framingham y Procam como estimadores del riesgo cardiovascular en una población colombiana Rev. Colomb]]></article-title>
<source><![CDATA[Cardiol]]></source>
<year>2014</year>
<volume>21</volume>
<page-range>202-12</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<collab>Expert Panel on Detection.Evaluation.and Treatment of High Blood Cholesterol in Adults</collab>
<article-title xml:lang=""><![CDATA[Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>2001</year>
<volume>285</volume>
<page-range>2486-97</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mancia]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Fagard]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Narkiewicz]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Redón]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Zanchetti]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Böhm]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[ESH/ESC Guidelines for the management of arterial hypertension the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)]]></article-title>
<source><![CDATA[J. Hypertens]]></source>
<year>2013</year>
<volume>31</volume>
<page-range>1281-357</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Machado-Alba Jorge]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Machado-Duque Manuel]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalencia de factores de riesgo cardiovascular en pacientes con dislipidemia afiliados al sistema de salud en Colombia Rev. Perú Med. Exp]]></article-title>
<source><![CDATA[Salud Pública]]></source>
<year>2013</year>
<volume>30</volume>
<page-range>205-11</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Navarro]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Vargas]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Riesgo coronario según ecuación de Framingham en adultos con síndrome metabólico de la ciudad de Soledad, Atlántico 2010. Rev. Colomb]]></article-title>
<source><![CDATA[Cardiol]]></source>
<year>2012</year>
<volume>19</volume>
<page-range>109-18</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bedoya-Ríos]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Mendoza-Lozano]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Nieto-Cárdenas]]></surname>
<given-names><![CDATA[OA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalencia de infarto de miocardio en un programa de riesgo cardiovascular de una institución prestadora de salud en Armenia.]]></article-title>
<source><![CDATA[. Rev. Colomb. Cardiol.]]></source>
<year>2016</year>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fernando]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Arrieta]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sociological study for detection of risk factors of cardiovascular diseases in the Colombian Caribbean Coast population]]></article-title>
<source><![CDATA[Rev. Colomb. Cardiol.]]></source>
<year>2005</year>
<volume>12</volume>
<page-range>122-8</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schargrodsky]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Champagne]]></surname>
<given-names><![CDATA[BM]]></given-names>
</name>
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Vinueza]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Silva Ay&#1195;aguer]]></surname>
<given-names><![CDATA[LC]]></given-names>
</name>
</person-group>
<collab>CARMELA Study Investigators</collab>
<article-title xml:lang=""><![CDATA[CARMELA assessment of cardiovascular risk in seven Latin American cities]]></article-title>
<source><![CDATA[Am J. Med.]]></source>
<year>2008</year>
<volume>121</volume>
<page-range>58-65</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alvarado]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Molina]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Zárate]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Toro]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estudio EPRAS estudio poblacional del riesgo cardiovascular de una población colombiana]]></article-title>
<source><![CDATA[Rev. Colomb. Cardiol.]]></source>
<year>2014</year>
<volume>21</volume>
<page-range>284-93</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lombo]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Villalobos]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Tique]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Satizábal]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Franco]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Metabolic syndrome prevalence in patients attending the hypertension clinic at the Fundación Santa Fe de Bogotá]]></article-title>
<source><![CDATA[Rev. Colomb. Cardiol.]]></source>
<year>2006</year>
<volume>12</volume>
<page-range>472-8</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Patiño-Villada]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Arango-Vélez]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Quintero-Velásquez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Arenas- Sosa]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cardiovascular risk factors in an urban Colombia population]]></article-title>
<source><![CDATA[Revista de Salud Pública]]></source>
<year>2011</year>
<volume>13</volume>
<page-range>433-45</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Múñoz]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[Á]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Higuera]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz]]></surname>
<given-names><![CDATA[Á]]></given-names>
</name>
<name>
<surname><![CDATA[Aschner]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guía de práctica clínica para la prevención, detección temprana, diagnóstico, tratamiento y seguimiento de las dislipidemias tratamiento farmacológico con estatinas. Rev. Colomb]]></article-title>
<source><![CDATA[Cardiol]]></source>
<year>2015</year>
<volume>22</volume>
<page-range>14-21</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
